Archives for December 2008

Cancer Institute Of New Jersey Receives Nearly $768,000 To Investigate A New Therapeutic Path Against Melanoma

With 2,300 New Jersey residents diagnosed with melanoma this year, the Garden State ranks sixth in the nation in new cases of the disease, according to the American Cancer Society. It is that statistic on which a scientist at The Cancer Institute of New Jersey (CINJ) hopes to have impact, thanks to a $768,000 [...]

28 December 2008 | Uncategorized | No Comments

LATISSE™ - New Prescription Product Increases Length, Thickness And Darkness Of Eyelashes

Allergan, Inc. (NYSE: AGN) today announced the U.S. Food and Drug Administration (FDA) has approved LATISSE™ (bimatoprost ophthalmic solution) 0.03% as a novel treatment for hypotrichosis of the eyelashes. Eyelash hypotrichosis is another name for having inadequate or not enough eyelashes. LATISSE™ is the first and only science-based treatment approved by the FDA to enhance [...]

27 December 2008 | Uncategorized | No Comments

Chorionic Villus Sampling May Increase Risk Of Hemangiomas

Performing chorionic villus sampling (CVS) for prenatal diagnosis may lead to an increased rate of blood vessel malformations called hemangiomas in infants, according to a review in the November Journal of Craniofacial Surgery.
Original post by Dermatology News From Medical News Today

25 December 2008 | Uncategorized | No Comments

Arpida Publishes Top-Line Data Of Phase II “Intravenous-To-Oral” Switch Trial With Oral Iclaprim

Arpida Ltd. (SWX: ARPN) announces positive top-line data of the Phase II ‘intravenous-to-oral’ switch trial with oral iclaprim in patients with complicated Skin and Skin Structure Infections (cSSSI). The top-line results demonstrated high clinical cure rates of over 90% following the step-down therapy with [...]

25 December 2008 | Dermatology | No Comments

Which? Bid To Stop Online Botox Promotions

eBay has agreed to remove illegal Botox adverts* from its popular site after Which? discovered over 240 instances of unlawful advertising of the product in just five days**. Sixteen companies and individuals were found advertising the prescription only medicine to the public, with many unaware they were breaking the law***.
Original post by [...]

24 December 2008 | Uncategorized | No Comments

Dangerous Skin Cancer

The German Cancer Society has worked out new guidelines for the diagnosis and treatment of malignant melanoma a disease with unfavorable prognosis. Malignant melanoma is responsible for 90% of deaths from skin cancer. The incidence has increased 5-fold within the last 30 years and UV radiation is thought to be an important cause. Caucasian populations [...]

23 December 2008 | Dermatology | No Comments

Basilea Pharmaceutica Opens U.S. Phase III Study On Alitretinoin For The Treatment Of Severe Chronic Hand Eczema

Basilea Pharmaceutica Ltd. (SWISS: BSLN) announces that it has opened a clinical phase III study on alitretinoin in the U.S. The “HANDEL” trial (HAND Eczema research of aLitretinoin) is the first ever multi-centered, controlled clinical study for patients with severe chronic hand eczema (CHE) performed in the U.S. “There is a real sense [...]

19 December 2008 | Dermatology | No Comments

Cleveland Clinic Surgeons Perform Nation’s First Near-Total Face Transplant

A multi-disciplinary team of doctors and surgeons at Cleveland Clinic recently performed the first near-total face transplant in the United States. In a 22-hour procedure performed within the past two weeks, surgeons transplanted 80 percent of a woman’s face who suffered severe facial trauma — essentially replacing her entire face, except for [...]

18 December 2008 | Uncategorized | No Comments

EpiDerm’s Skin Irritation Test Fully Validated In European Union

MatTek Corporation announced that the ECVAM Scientific Advisory Committee (ESAC) endorsed the scientific validity of the Modified EpiDerm Skin Irritation Test (SIT) at its November meeting. ESAC concluded that the Modified EpiDerm SIT has sufficient accuracy and reliability for the prediction of skin irritating and non-irritating test substances. The Updated EpiDerm SIT [...]

18 December 2008 | Uncategorized | No Comments

Psoriasis Patients Have Higher Levels Of Obesity Hormone Leptin

The skin disease psoriasis has been associated with higher levels of the protein leptin, according to an article released on December 15, 2008 in Archives of Dermatology, one of the JAMA/Archives journals. Psoriasis is a chronic autoimmune disease whose primary symptom is the presence of a persistent red, scaly [...]

18 December 2008 | Uncategorized | No Comments

Navigation

News Archives

Sponsors